BIIB vs MSFT: Which Stock is Better?
Side-by-side comparison of Biogen Inc and Microsoft Corp in 2026
BIIB
Biogen Inc
$184.02
MSFT
Microsoft Corp
$397.23
Key Metrics Comparison
| Metric | BIIB | MSFT | Winner |
|---|---|---|---|
| Market Cap | $27.01B | N/A | BIIB |
| P/E Ratio | 21.42 | 36.30 | BIIB |
| EPS (TTM) | $8.59 | $13.70 | MSFT |
| Revenue Growth | -0.1% | 14.9% | MSFT |
| Gross Margin | 78.9% | 68.8% | BIIB |
Analyze BIIB
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BIIB or MSFT a better investment?
Comparing BIIB and MSFT: Biogen Inc has a market cap of $27.01B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BIIB and MSFT?
BIIB (Biogen Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BIIB or MSFT?
Based on P/E ratios, BIIB trades at a lower multiple (21.4x vs 36.3x).
Which is growing faster: BIIB or MSFT?
MSFT has higher revenue growth at 14.9% vs -0.1% for BIIB.
Which company is more profitable: BIIB or MSFT?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 68.8% for MSFT.
Which is the larger company: BIIB or MSFT?
Biogen Inc (BIIB) is larger with a market cap of $27.01B compared to N/A for MSFT.
Should I buy BIIB or MSFT in 2026?
Both BIIB and MSFT have investment merit. BIIB trades at $184.02 while MSFT trades at $397.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BIIB and MSFT stock?
Key differences: Market Cap ($27.01B vs N/A), P/E Ratio (21.4x vs 36.3x), Revenue Growth (-0.1% vs 14.9%), Gross Margin (78.9% vs 68.8%).